Crinetics Pharmaceuticals, Inc.

MORGAN STANLEY CRNX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

768,826

Value ($000)

35,789

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	35,789	0.0%	768,826	12/31/2025
2025 Q3	11/14/2025	28,411	0.0%	682,134	9/30/2025
2025 Q2	8/14/2025	21,858	0.0%	760,022	6/30/2025
2025 Q1	5/15/2025	17,263	0.0%	514,684	3/31/2025
2024 Q4	5/15/2025	25,823	0.0%	505,040	12/31/2024
2024 Q3	5/14/2025	34,012	0.0%	665,599	9/30/2024
2024 Q2	5/14/2025	37,562	0.0%	838,625	6/30/2024
2024 Q1	5/15/2024	28,657	0.0%	612,200	3/31/2024
2023 Q4	2/13/2024	23,065	0.0%	648,251	12/31/2023
2023 Q3	11/15/2023	15,207	0.0%	511,321	9/30/2023
2023 Q2	8/14/2023	13,446	0.0%	746,159	6/30/2023
2023 Q1	5/15/2023	10,486	0.0%	652,916	3/31/2023
2022 Q4	2/14/2023	2,792	0.0%	152,588	12/31/2022
2022 Q3	11/14/2022	2,004	0.0%	102,032	9/30/2022
2022 Q2	10/27/2022	2,605	0.0%	139,616	6/30/2022
2022 Q1	10/27/2022	2,092	0.0%	95,290	3/31/2022
2021 Q4	2/14/2022	1,079	0.0%	37,978	12/31/2021
2021 Q3	11/15/2021	1,451	0.0%	68,954	9/30/2021
2021 Q2	8/23/2021	3,430	0.0%	181,997	6/30/2021
2021 Q1	5/17/2021	3,068	0.0%	200,753	3/31/2021
2020 Q4	2/16/2021	2,620	0.0%	185,742	12/31/2020
2020 Q3	11/13/2020	638	0.0%	40,706	9/30/2020
2020 Q2	8/14/2020	3,745	0.0%	213,821	6/30/2020
2020 Q1	5/26/2020	34	0.0%	2,251	3/31/2020
2019 Q4	2/14/2020	437	0.0%	17,407	12/31/2019